US2005208547A1PendingUtilityA1

Oligonucleotide for detecting Salmonella and method of detecting Salmonella

Assignee: TOSOH CORPPriority: Jan 17, 2001Filed: Feb 2, 2005Published: Sep 22, 2005
Est. expiryJan 17, 2021(expired)· nominal 20-yr term from priority
C12Q 1/689Y02A50/30C12Q 1/6865
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides oligonucleotides for detecting Salmonella toxin gene invA mRNA and stn mRNA which oligonucleotides specifically bind to invA mRNA or stn mRNA at a relatively low temperature (for example, 41° C.) and at a constant temperature, and a process of amplifying Salmonella toxin gene invA mRNA or stn mRNA and a method of detecting the same using the oligonucleotides.

Claims

exact text as granted — not AI-modified
1 - 3 . (canceled)  
     
     
         4 . A process of amplifying  Salmonella  gene stn mRNA having a specific sequence, comprising 
 obtaining a sample comprising  Salmonella  gene stn mRNA    synthesizing cDNA employing an RNA-dependent DNA polymerase resulting in an RNA/DNA hybrid,    digesting the RNA of the RNA/DNA hybrid with Ribonuclease H to produce a single-stranded DNA,    producing a double-stranded DNA having a promoter sequence capable of transcribing RNA comprising said specific sequence or a sequence complementary to said specific sequence employing a DNA-dependent DNA polymerase, wherein said single-stranded DNA is the template for said producing and wherein said double-stranded DNA produces an RNA transcription product in the presence of an RNA polymerase, and    synthesizing cDNA comprising annealing an oligonucleotide primer pair consisting of (a) a sequence selected from the group consisting of SEQ ID NOs: 13 to 18 and (b) a sequence selected from the group consisting of SEQ ID NOs: 24 to 27 to said RNA transcription product and amplifying said cDNA by employing said RNA-dependent DNA polymerase, where either primer includes an RNA polymerase promoter sequence at the 5′ end.    
     
     
         5 . The process according to  claim 4 , which is a detection method, wherein said amplifying is performed in the presence of an oligonucleotide probe which has a sequence that is complementary to at least a portion of the RNA transcription product, is labeled with an intercalator fluorescent pigment, and has a sequence different from said oligonucleotide primer pair, wherein changes in the fluorescent properties of the intercalator are measured.  
     
     
         6 . The detection method according to  claim 5 , wherein said probe is designed so as to complementarily bind to at least a portion of the sequence of said RNA transcription product, and the fluorescent property changes relative to that of a situation where a complex formation is absent.  
     
     
         7 . (canceled)  
     
     
         8 . The detection method according to  claim 6 , wherein said probe for detecting said stn mRNA comprises at least 10 contiguous bases of SEQ. ID. No. 29 or its complementary sequence.  
     
     
         9 . The process of  claim 4 , wherein said annealing is at a temperature ranging from 35 to 50° C.  
     
     
         10 . The process of  claim 4 , wherein said amplifying said cDNA is at a temperature ranging from 35 to 50° C.  
     
     
         11 . The process of  claim 10 , wherein said amplifying said cDNA is at a constant temperature.  
     
     
         12 . The process of  claim 4 , wherein the process is performed by employing a single enzyme having RNA-dependent DNA polymerase activity, DNA-dependent DNA-polymerase activity, and ribonuclease H activity.  
     
     
         13 . The process of  claim 12 , wherein said enzyme is AMV reverse transcriptase.  
     
     
         14 . The process of  claim 4 , wherein said RNA polymerase is a T7 phage RNA polymerase or a SP6 phage RNA polymerase.  
     
     
         15 . The process of  claim 4 , wherein said sequence selected from the group consisting of SEQ ID NOs: 13 to 18 is the sequence of SEQ ID NO: 15.  
     
     
         16 . The process of  claim 4 , wherein said sequence selected from the group consisting of SEQ ID NOs: 24 to 27 is the sequence of SEQ ID NO: 25.  
     
     
         17 . The detection method according to  claim 5 , wherein said intercalator fluorescent pigment is bonded to a phosphorus atom in the oligonucleotide probe through a linker.  
     
     
         18 . The detection method according to  claim 5 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group such that extension from said probe is inhibited.  
     
     
         19 . The detection method according to  claim 18 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group by addition of a glycolic acid.  
     
     
         20 . The detection method according to  claim 5 , wherein said sequence selected from the group consisting of SEQ ID NOs: 13 to 18 is the sequence of SEQ ID NO: 15.  
     
     
         21 . detection method according to  claim 5 , wherein said sequence selected from the group consisting of SEQ ID NOs: 24 to 27 is the sequence of SEQ ID NO: 25.  
     
     
         22 . The detection method according to  claim 8 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group such that extension from said probe is inhibited.  
     
     
         23 . The detection method according to  claim 22 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group by addition of a glycolic acid.

Join the waitlist — get patent alerts

Track US2005208547A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.